Skip to main content
Advertisement
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
      • Doodle Gallery
      • Circulation Cover Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
      • Hospital Santa Maria del Popolo, Naples, Italy
      • Minneapolis City Hospital
      • Pitié-Salpêtrière Hospital
      • Tufts Medical Center
      • Uppsala University Hospital
      • Vassar Brothers Medical Center (Poughkeepsie, NY)
      • Wroclaw Medical University
    • On My Mind
    • Podcast Archive
      • → Circulation on the Run, FIT Edition
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
      • Accepted Manuscripts
      • Revised Manuscripts
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
    • On My Mind
    • Podcast Archive
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association

Search for author "Tuo Zhang"

  • Modify Search
  • Create Alert
  • Save Search

28 Results

Type a term to search within all articles in this journal: e.g., stem cell
Content Type
Select types of content to include in the results.
Citation
Citation-specific search information
e.g., 2009
e.g., 20
e.g., 3
e.g., 29
e.g., 10.9999/123XYZ456
Authors, Keywords
Search for specific authors and/or words and phrases.
e.g., Smith, JS
e.g., Smith, JS
Type any phrase that appears in the article title
Type any phrase that appears within article title or abstract
Type any phrase that appears within article body, title or abstract
e.g., Smith, JS
Book publisher name
Limit Results
Limit search results by date
e.g., 08/01/2017
e.g., 08/01/2017
Format Results
  • You have accessRestricted access
    Abstract 451: PNS-R1 Attenuates the Development of Atherosclerosis in ApoE-Deficient Mouse Model
    Yu Chen, Chenglin Jia, Minqi Xiong, Jingang Cui, Qinbo Yang and Teng Zhang
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2014;34:A451
  • You have accessRestricted access
    Abstract 451: PNS-R1 Attenuates the Development of Atherosclerosis in ApoE-Deficient Mouse Model
    Yu Chen, Chenglin Jia, Minqi Xiong, Jingang Cui, Qinbo Yang and Teng Zhang
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2014;34:A451
  • You have accessRestricted access
    Upregulation of a Disintegrin and Metalloproteinase With Thrombospondin Motifs-7 by miR-29 Repression Mediates Vascular Smooth Muscle Calcification
    Yaoyao Du, Cheng Gao, Ziyi Liu, Li Wang, Bo Liu, Fan He, Tao Zhang, Yue Wang, Xiujie Wang, Mingjiang Xu, Guan-Zheng Luo, Yi Zhu, Qingbo Xu, Xian Wang and Wei Kong
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2012;32:2580-2588, originally published October 17, 2012
    https://doi.org/10.1161/ATVBAHA.112.300206
    Download PDF
  • You have access
    Upregulation of a Disintegrin and Metalloproteinase With Thrombospondin Motifs-7 by miR-29 Repression Mediates Vascular Smooth Muscle Calcification
    Yaoyao Du, Cheng Gao, Ziyi Liu, Li Wang, Bo Liu, Fan He, Tao Zhang, Yue Wang, Xiujie Wang, Mingjiang Xu, Guan-Zheng Luo, Yi Zhu, Qingbo Xu, Xian Wang, Wei Kong
    Arteriosclerosis, Thrombosis, and Vascular Biology November 2012, 32 (11) 2580-2588; DOI: https://doi.org/10.1161/ATVBAHA.112.300206
    Figure 1.
    Figure 1.
    A disintegrin and metalloproteinase with thrombospondin motifs-7 (ADAMTS-7) expression is upregulated in cal...
    Show More
    A disintegrin and metalloproteinase with thrombospondin motifs-7 (ADAMTS-7) expression is upregulated in calcifying vascular smooth muscle cells (VSMCs) and arteries. A, Representative Western blot analysis and quantification of ADAMTS-7 protein level in radial arteries of patients. Chronic renal failure (CRF): patients with chronic renal failure and uremia who underwent arterial venous fistular surgery (n=4); control (n=5): patients with chronic heart disease but not diabetes or chronic kidney disease who underwent coronary artery bypass grafting. Data are means±SEM normalized to that of GAPDH. *P<0.05. B, Representative Western blot and quantification of ADAMTS-7 protein level in abdominal aortas of rats with CRF treated with sham operation, calcitriol, 5/6 nephrectomization, or 5/6 nephrectomization plus calcitriol (n=5–7 per group). *P<0.05 vs sham control. C and E, Quantification of relative ADAMTS-7 mRNA level during short- (C) and long-term (E) high-phosphate stimulation in rat VSMCs. Representative Western blot and quantification of ADAMTS-7 protein level during short- (D) and long-term (F) high-phosphate stimulation (2.6 mmol/L) in rat VSMCs. Normalization was to β-actin. Data are means±SEM from 3 independent experiments performed in duplicate. *P<0.05 vs 0 hour or control.
    Show Less
  • You have access
    Upregulation of a Disintegrin and Metalloproteinase With Thrombospondin Motifs-7 by miR-29 Repression Mediates Vascular Smooth Muscle Calcification
    Yaoyao Du, Cheng Gao, Ziyi Liu, Li Wang, Bo Liu, Fan He, Tao Zhang, Yue Wang, Xiujie Wang, Mingjiang Xu, Guan-Zheng Luo, Yi Zhu, Qingbo Xu, Xian Wang, Wei Kong
    Arteriosclerosis, Thrombosis, and Vascular Biology November 2012, 32 (11) 2580-2588; DOI: https://doi.org/10.1161/ATVBAHA.112.300206
    Figure 2.
    Figure 2.
    A disintegrin and metalloproteinase with thrombospondin motifs-7 (ADAMTS-7) facilitates vascular smooth musc...
    Show More
    A disintegrin and metalloproteinase with thrombospondin motifs-7 (ADAMTS-7) facilitates vascular smooth muscle cell (VSMC) calcification in vitro. A, Western blot analysis of the levels of ADAMTS-7 protein, cartilage oligomeric matrix protein (COMP) degradation, bone morphogenetic protein-2 (BMP-2) protein, and total and phosphorylated Smad1/5/8, runt-related transcription factor 2 (Rnx2) and msh homeobox 2 (Msx2) proteins with adenovirus (Ad)-green fluorescent protein (GFP) or Ad-ADAMTS-7 infection at day 6 after high-phosphate stimulation. Pi indicates high phosphate (2.6 mmol/L). Quantification of calcium deposition (B) and Alizarin red S staining (C) with Ad-GFP or Ad-ADAMTS-7 infection at day 12 after high-phosphate stimulation. D, Western blot analysis with 50 nmol/L scramble or ADAMTS-7 small interfering RNA (siRNA) at day 6 after high-phosphate stimulation. Quantification of calcium deposition (E) and Alizarin red S staining (F) with scramble or ADAMTS-7 siRNA at day 12 after stimulation. Data are means±SEM from 3 independent experiments performed in duplicate. *P<0.05. Reddish/purple staining indicates mineral deposition. Scale bar, 20 μm. G, Quantification of calcium deposition with Ad-GFP, Ad-ADAMTS-7, or Ad-ADAMTS-7 plus Ad-COMP after high-phosphate stimulation.
    Show Less
  • You have access
    Upregulation of a Disintegrin and Metalloproteinase With Thrombospondin Motifs-7 by miR-29 Repression Mediates Vascular Smooth Muscle Calcification
    Yaoyao Du, Cheng Gao, Ziyi Liu, Li Wang, Bo Liu, Fan He, Tao Zhang, Yue Wang, Xiujie Wang, Mingjiang Xu, Guan-Zheng Luo, Yi Zhu, Qingbo Xu, Xian Wang, Wei Kong
    Arteriosclerosis, Thrombosis, and Vascular Biology November 2012, 32 (11) 2580-2588; DOI: https://doi.org/10.1161/ATVBAHA.112.300206
    Figure 3.
    Figure 3.
    A disintegrin and metalloproteinase with thrombospondin motifs-7 (ADAMTS-7) aggravates aortic ring calcifica...
    Show More
    A disintegrin and metalloproteinase with thrombospondin motifs-7 (ADAMTS-7) aggravates aortic ring calcification. A, Western blot analysis of ADAMTS-7 protein level in rat abdominal arteries transfected with adenovirus (Ad)-green fluorescent protein (GFP) or Ad-ADAMTS-7 at day 3 after infection. Rat aortas were then cut into aortic rings and cultured in DMEM or calcifying medium containing 3.8 mmol/L PO43− for 6 days. Quantification of calcium deposition in ADAMTS-7–transfected aortic rings at day 6. B, Western blot verification of ADAMTS-7 knockdown in rat carotid arteries with scramble or ADAMTS-7 small interfering RNA (siRNA) for 3 days. The aortas were cut into aortic rings and cultured in DMEM or calcifying medium for 6 days. Quantification of calcium deposition in aortic rings with ADAMTS-7 knockdown at day 6. Data are means±SEM from 3 independent experiments performed in triplicate. *P<0.05.
    Show Less
  • You have access
    Upregulation of a Disintegrin and Metalloproteinase With Thrombospondin Motifs-7 by miR-29 Repression Mediates Vascular Smooth Muscle Calcification
    Yaoyao Du, Cheng Gao, Ziyi Liu, Li Wang, Bo Liu, Fan He, Tao Zhang, Yue Wang, Xiujie Wang, Mingjiang Xu, Guan-Zheng Luo, Yi Zhu, Qingbo Xu, Xian Wang, Wei Kong
    Arteriosclerosis, Thrombosis, and Vascular Biology November 2012, 32 (11) 2580-2588; DOI: https://doi.org/10.1161/ATVBAHA.112.300206
    Figure 4.
    Figure 4.
    A disintegrin and metalloproteinase with thrombospondin motifs-7 (ADAMTS-7) is a functional target of miR-29...
    Show More
    A disintegrin and metalloproteinase with thrombospondin motifs-7 (ADAMTS-7) is a functional target of miR-29a/b in vascular smooth muscle cells (VSMCs). A, Schematic diagram and alignment of miR-29a/b target region within the 3′ untranslated region (UTR) of ADAMTS-7 in human, rat, mouse, and dog. The highly conserved seed sequences of miR-29a/b complementary to ADAMTS-7 3′ UTR are boxed. B, Luciferase activity of reporter constructs containing the 3′ UTR of ADAMTS-7 (deletion or mutation; with the 6-nt seed sequence deleted or mutated). Quantitative real-time polymerase chain reaction and representative Western blot analysis of VSMCs with ADAMTS-7 expression inhibited by mimic miR-29a/b (C) but upregulated by anti–miR-29a/b (D). β-actin was an internal control. Data are means±SEM from 3 independent experiments performed in duplicate. *P<0.05 compared with control. WT indicates wild type.
    Show Less
  • You have access
    Upregulation of a Disintegrin and Metalloproteinase With Thrombospondin Motifs-7 by miR-29 Repression Mediates Vascular Smooth Muscle Calcification
    Yaoyao Du, Cheng Gao, Ziyi Liu, Li Wang, Bo Liu, Fan He, Tao Zhang, Yue Wang, Xiujie Wang, Mingjiang Xu, Guan-Zheng Luo, Yi Zhu, Qingbo Xu, Xian Wang, Wei Kong
    Arteriosclerosis, Thrombosis, and Vascular Biology November 2012, 32 (11) 2580-2588; DOI: https://doi.org/10.1161/ATVBAHA.112.300206
    Figure 5.
    Figure 5.
    miR-29a/b level is suppressed in calcifying vascular smooth muscle cells (VSMCs) and arteries. A...
    Show More
    miR-29a/b level is suppressed in calcifying vascular smooth muscle cells (VSMCs) and arteries. A and B, Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of mRNA level of miR-29a/b in VSMCs treated without or with short- (A) and long-term (B) high phosphate. RNU5G was an internal control. Data are means±SEM from 3 independent experiments. *P<0.05 vs 0 hour or control. C, Argonaut 2 (Ago2) pull-down assay. Quantitative RT-PCR analysis of mRNA level of miR-29a/b in Ago2 complex in VSMCs stimulated with high phosphate for various times. *P<0.05 vs 0 hour. D, Quantitative RT-PCR analysis of mRNA level of miR-29a/b in rat abdominal aortas with sham operation, calcitriol, 5/6 nephrectomization, or 5/6 nephrectomization plus calcitriol at the time rats were euthanized (n=5–7 per group). *P<0.05 vs sham. E, Quantification of miR-29a/b level in the radial arteries of patients with chronic renal failure. Chronic renal failure (CRF): uremic patients who underwent arterial venous fistular operation (n=5); control (n=5): patients with coronary heart disease who underwent coronary artery bypass grafting. Data are means±SEM normalized to that of RNU5G. *P<0.05. F, Quantification of miR-29a/b level in VSMCs stimulated with high phosphate and infected with Ad-IκB or Ad-LacZ (50 multiplicity of infection) at 1 hour. *P<0.05.
    Show Less
  • You have access
    Upregulation of a Disintegrin and Metalloproteinase With Thrombospondin Motifs-7 by miR-29 Repression Mediates Vascular Smooth Muscle Calcification
    Yaoyao Du, Cheng Gao, Ziyi Liu, Li Wang, Bo Liu, Fan He, Tao Zhang, Yue Wang, Xiujie Wang, Mingjiang Xu, Guan-Zheng Luo, Yi Zhu, Qingbo Xu, Xian Wang, Wei Kong
    Arteriosclerosis, Thrombosis, and Vascular Biology November 2012, 32 (11) 2580-2588; DOI: https://doi.org/10.1161/ATVBAHA.112.300206
    Figure 6.
    Figure 6.
    miR-29a/b inhibits vascular smooth muscle cell (VSMC) calcification by upregulating a disintegrin and metall...
    Show More
    miR-29a/b inhibits vascular smooth muscle cell (VSMC) calcification by upregulating a disintegrin and metalloproteinase with thrombospondin motifs-7 (ADAMTS-7). A and B, Representative Western blot of protein expression and quantification of calcium deposition in CaCl2 and miR-29 mimic- or inhibitor-treated rat carotid arteries at day 7. Rat carotid arteries were periadventially treated with 10 μg control mimic miR or mimic miR-29a/b after CaCl2 treatment. Rat carotid arteries were periadventially treated with control anti-miR or anti–miR-29a/b after CaCl2 treatment. Data are means±SEM from 3 independent experiments. *P<0.05. C, Calcium deposition of VSMCs. VSMCs were transfected with control anti-miR or anti–miR-29a/b, then underwent scramble or ADAMTS-7 small interfering RNA (siRNA) transfection and high-phosphate stimulation for an additional 12 days. Data are means±SEM from 3 independent experiments performed in triplicate. *P<0.05. COMP indicates cartilage oligomeric matrix protein; BMP-2, bone morphogenetic protein-2.
    Show Less
  • You have accessRestricted access
    Upregulation of a Disintegrin and Metalloproteinase With Thrombospondin Motifs-7 by miR-29 Repression Mediates Vascular Smooth Muscle Calcification
    Yaoyao Du, Cheng Gao, Ziyi Liu, Li Wang, Bo Liu, Fan He, Tao Zhang, Yue Wang, Xiujie Wang, Mingjiang Xu, Guan-Zheng Luo, Yi Zhu, Qingbo Xu, Xian Wang and Wei Kong
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2012;32:2580-2588, originally published October 17, 2012
    https://doi.org/10.1161/ATVBAHA.112.300206
    Download PDF

Pages

  • 1
  • 2
  • 3
  • Next Page
Back to top

Selected Facets

Selected Facets

  • Arteriosclerosis, Thrombosis, and Vascular Biology (Source)

Publication Date

Publication date

  • 2013-2016 2
  • 2008-2012 26

Article Type

Article Type

  • Animal models of human disease 7
  • Integrative Physiology/Experimental Medicine 24
  • Oral Abstract Presentations 2
  • Oral Abstract Presentations Session Title: Concurrent Session I D - Clinical Lipidology: Diagnosis and Therapeutics 1
  • Other Vascular biology 7
  • Poster Abstract Presentations 2
  • Poster Abstract Presentations Session Title: Poster Session II 1
  • Session Title: Concurrent Session I D - Clinical Lipidology: Diagnosis and Therapeutics 2
  • Session Title: Poster Session II 2
  • Volume 32, Issue 5 Supplement; May 2012 / Abstracts From the Arteriosclerosis, Thrombosis and Vascular Biology 2012 Scientific Sessions 2
  • Show More
  • Show Less

Subject

Subject

  • Animal models of human disease 14
  • Other Vascular biology 14
  • Volume 32, Issue 5 Supplement; May 2012 / Abstracts From the Arteriosclerosis, Thrombosis and Vascular Biology 2012 Scientific Sessions 2

Content Type

Resource Type

  • Articles 8
  • Tables & Figures 20
Advertisement
Advertisement

Circulation

  • About Circulation
  • Instructions for Authors
  • Circulation CME
  • Statements and Guidelines
  • Meeting Abstracts
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
200 Fifth Avenue, Suite 1020
Waltham, MA 02451
email: circ@circulationjournal.org
 

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2017 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured